世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の創薬アウトソーシング市場 2018-2022年

Global Drug Discovery Outsourcing Market 2018-2022

 

出版社 出版年月電子版価格 ページ数
TechNavio
テクナビオ
2018年2月US$2,500
シングルユーザライセンス
123

サマリー

このレポートは世界の創薬アウトソーシング市場を調査したTechNavioの調査報告書です。

Report Details

About Drug Discovery Outsourcing

Drug discovery outsourcing refers to the outsourcing of drug discovery processes to contract manufacturers to reduce the time taken for development of a drug or to scale-up production, enjoy premium pricing, increase market share, reduce costs, and serve the local markets.

Technavio’s analysts forecast the global drug discovery outsourcing market to grow at a CAGR of 12.13% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global drug discovery outsourcing market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, Global Drug Discovery Outsourcing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Charles River
- Domainex
- EVOTEC
- GenScript
- GVK Biosciences

Market driver
- Prioritization of core competencies
- For a full, detailed list, view our report

Market challenge
- Limited manufacturing standardization
- For a full, detailed list, view our report

Market trend
- Increased demand for regenerative medicine
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2022 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.




目次

Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 05: MARKET SIZING
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
- Segmentation by product
- Comparison by product
- Small molecules? Market size and forecast 2017-2022
- Biologics - Market size and forecast 2017-2022
- Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Americas - Market size and forecast 2017-2022
- EMEA - Market size and forecast 2017-2022
- APAC - Market size and forecast 2017-2022
- Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 12: MARKET TRENDS
- Increased demand for regenerative medicine
- Increased number of M&A
- Presence of value-added services
PART 13: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 14: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Charles River
- Domainex
- EVOTEC
- GenScript
- GVK Biosciences
- Laboratory Corporation of America
- Other prominent vendors
PART 15: APPENDIX
- List of abbreviations
List of Exhibits
Exhibit 01: Related market
Exhibit 02: Market characteristics
Exhibit 03: Market segments
Exhibit 04: Market definition - Inclusions and exclusions checklist
Exhibit 05: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global drug discovery outsourcing market - Market size and forecast 2017-2022 ($ bn)
Exhibit 08: Global drug discovery outsourcing market - Year over year growth 2018-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2017-2022
Exhibit 17: Product - Market share 2017-2022 (%)
Exhibit 18: Comparison by product
Exhibit 19: Small molecules? Market size and forecast 2017-2022 ($ bn)
Exhibit 20: Characteristics of small molecules drugs compared with biologics
Exhibit 21: Small molecules? Year over year growth 2018-2022 (%)
Exhibit 22: Biologics? Market size and forecast 2017-2022 ($ bn)
Exhibit 23: Biologics? Year over year growth 2018-2022 (%)
Exhibit 24: Popular biologics
Exhibit 25: Market opportunity by product
Exhibit 26: Customer landscape
Exhibit 27: Global - Market share by geography 2017-2022 (%)
Exhibit 28: Regional comparison
Exhibit 29: Americas - Market size and forecast 2017-2022 ($ bn)
Exhibit 30: Americas - Year over year growth 2018-2022 (%)
Exhibit 31: Top three countries in Americas
Exhibit 32: EMEA - Market size and forecast 2017-2022 ($ bn)
Exhibit 33: EMEA - Year over year growth 2018-2022 (%)
Exhibit 34: Top three countries in EMEA
Exhibit 35: APAC - Market size and forecast 2017-2022 ($ bn)
Exhibit 36: APAC - Year over year growth 2018-2022 (%)
Exhibit 37: Top three countries in APAC
Exhibit 38: Market opportunity
Exhibit 39: Competitive advantage among vendors
Exhibit 40: Examples of global pharmaceutical companies sourcing from contract manufacturers
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendors Covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Vendor overview
Exhibit 48: Charles River - Business segments
Exhibit 49: Charles River - Organizational developments
Exhibit 50: Charles River - Geographic focus
Exhibit 51: Charles River - Segment focus
Exhibit 52: Charles River - Key offerings
Exhibit 53: Vendor overview
Exhibit 54: Domainex - Business segments
Exhibit 55: Domainex - Organizational developments
Exhibit 56: Domainex - Geographic focus
Exhibit 57: Domainex - Segment focus
Exhibit 58: Domainex - Key offerings
Exhibit 59: Vendor overview
Exhibit 60: EVOTEC? Business segments
Exhibit 61: EVOTEC? Organizational developments
Exhibit 62: EVOTEC? Geographic focus
Exhibit 63: EVOTEC? Segment focus
Exhibit 64: EVOTEC? Key offerings
Exhibit 65: Vendor overview
Exhibit 66: GenScript? Business segments
Exhibit 67: GenScript? Organizational developments
Exhibit 68: GenScript? Geographic focus
Exhibit 69: GenScript? Segment focus
Exhibit 70: GenScript? Key offerings
Exhibit 71: Vendor overview
Exhibit 72: GVK Biosciences? Business segments
Exhibit 73: GVK Biosciences? Organizational developments
Exhibit 74: GVK Biosciences? Geographic focus
Exhibit 75: GVK Biosciences? Segment focus
Exhibit 76: GVK Biosciences? Key offerings
Exhibit 77: Vendor overview
Exhibit 78: Laboratory Corporation of America? Business segments
Exhibit 79: Laboratory Corporation of America? Organizational developments
Exhibit 80: Laboratory Corporation of America? Geographic focus
Exhibit 81: Laboratory Corporation of America? Segment focus
Exhibit 82: Laboratory Corporation of America? Key offerings

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る